Dr. Lodberg is a physician-scientist specializing in molecular endocrinology, focusing on activin receptor signaling in muscle and bone metabolism. His work bridges basic and translational research, developing diagnostic bioassays (e.g., free cortisol measurement) and platform technologies for intracellular drug delivery and targeted therapeutic localization. His research aims to advance precision medicine for musculoskeletal and endocrine diseases.

Dr. Lodberg currently teaches gross anatomy, with over 300 contact hours in histology, embryology, biochemistry, and bone biology.

Dr. Lodberg has several ongoing academic collaborations, including:

Danish institutions:

Aarhus University Hospital

Department of Biomedicine at Aarhus University

Copenhagen University

Herlev Hospital

Odense University Hospital

Rigshospitalet

International institutions:

Erasmus MC

Münster University

Swiss Center for Musculoskeletal Biobanking

Industry collaborations:

Keros Therapeutics

Novo Nordisk

Dr. Lodberg has provided consultancy for:

Biotechnology and pharmaceutical companies:

Arcarios

Aureka Biotechnologies

Bluejay Therapeutics

Epirium Bio

Keros Therapeutics

Novo Nordisk

Financial and investment firms:

Morgan Stanley